Within-host acquisition of colistin-resistance of an NDM-producing Klebsiella quasipneumoniae subsp. similipneumoniae strain through the insertion sequence-903B-mediated inactivation of mgrB gene in a lung transplant child in China

被引:1
作者
Wu, Yongli [1 ,2 ,3 ]
Zhao, Jiankang [2 ,3 ]
Li, Ziyao [2 ,3 ,4 ]
Liu, Xinmeng [2 ,3 ,5 ]
Hu, Yanning [2 ,3 ,5 ]
Zhang, Feilong [2 ,3 ,5 ]
Zhang, Yulin [2 ,3 ]
Pu, Danni [1 ,2 ,3 ]
Li, Chen [5 ]
Zhuo, Xianxia [2 ,3 ,6 ]
Shi, Huihui [7 ]
Lu, Binghuai [1 ,2 ,3 ,4 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Natl Ctr Resp Med, Dept Pulm & Crit Care Med, Lab Clin Microbiol & Infect Dis, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
[4] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China
[5] Peking Univ, China Japan Friendship Sch Clin Med, Dept Pulm & Crit Care Med, Beijing, Peoples R China
[6] Capital Med Univ China, Japan Friendship Sch Clin Med, Dept Pulm & Crit Care Med, Beijing, Peoples R China
[7] Shanghai Univ, Nantong Hosp, Dept Clin Lab, Nantong, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2023年 / 13卷
关键词
Klebsiella quasipneumoniae subsp. similipneumoniae; colistin; mgrB gene; insertional sequence; within-host evolution; ESCHERICHIA-COLI; PNEUMONIAE; ENTEROBACTERIACEAE; HETERORESISTANCE; CARBAPENEMASES; EMERGENCE; MECHANISM;
D O I
10.3389/fcimb.2023.1153387
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Colistin, as the antibiotic of "last resort" for carbapenem-resistant Klebsiella, develop resistance during administration of this antimicrobial agent. We identified an NDM-1-producing Klebsiella quasipneumonuae subsp. similipneumoniae (KQSS) strain KQ20 605 recovered from a child, which developed resistance to colistin (KQ20786) through acquiring an IS903B element between the-27th and-26th bp of mgrB promoter region after 6-day colistin usage. Objectives: The aim of this study is to explore the source of IS903B in the disruptive mgrB gene and its underlying mechanisms. Materials and methods: Antibiotics susceptibility testing was conducted via microbroth dilution method. The in vitro colistin-induced experiment of KQ20605 was performed to mimic the in vivo transition from colistin-sensitive to resistant. Whole-genome sequencing was used to molecular identification of colistin resistance mechanism. Results: The IS903B element integrated into mgrB gene of KQ20786 had a 100% nucleotide identity and coverage match with one IS903B on plasmid IncR, and only 95.1% (1005/1057) identity to those on chromosome. In vitro, upon the pressure of colistin, KQ20605 could also switch its phenotype from colistinsensitive to resistant with IS elements (e.g., IS903B and IS26) frequently inserted into mgrB gene at "hotspots", with the insertion site of IS903B nearly identical to that of KQ20786. Furthermore, IS26 elements in this isolate were only encoded by plasmids, including IncR and conjugative plasmid IncN harboring blaNDM. Conclusion: Mobilizable IS elements on plasmids tend to be activated and integrated into mgrB gene at "hotspots" in this KQSS, thereby causing the colistin resistance emergence and further dissemination.
引用
收藏
页数:11
相关论文
共 32 条
[1]   Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019) [J].
Ahmed, Mohamed Abd El-Gawad El-Sayed ;
Zhong, Lan-Lan ;
Shen, Cong ;
Yang, Yongqiang ;
Doi, Yohei ;
Tian, Guo-Bao .
EMERGING MICROBES & INFECTIONS, 2020, 9 (01) :868-885
[2]   Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis [J].
Binsker, Ulrike ;
Kaesbohrer, Annemarie ;
Hammerl, Jens A. .
FEMS MICROBIOLOGY REVIEWS, 2022, 46 (01)
[3]  
Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/ERI.12.78, 10.1586/eri.12.78]
[4]   MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin [J].
Cannatelli, Antonio ;
Giani, Tommaso ;
D'Andrea, Marco Maria ;
Di Pilato, Vincenzo ;
Arena, Fabio ;
Conte, Viola ;
Tryfinopoulou, Kyriaki ;
Vatopoulos, Alkiviadis ;
Rossolini, Gian Maria .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (10) :5696-5703
[5]   In Vivo Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP mgrB Regulator [J].
Cannatelli, Antonio ;
D'Andrea, Marco Maria ;
Giani, Tommaso ;
Di Pilato, Vincenzo ;
Arena, Fabio ;
Ambretti, Simone ;
Gaibani, Paolo ;
Rossolini, Gian Maria .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) :5521-5526
[6]  
CLSI, 2022, Performance standards for antimicrobial susceptibility testing, V32nd
[7]   Insertion sequences disrupting mgrB in carbapenem-resistant Klebsiella pneumoniae strains in Brazil [J].
da Silva, Daniely Martins ;
Faria-Junior, Celio ;
Nery, Danielly Rocha ;
de Oliveira, Pamela Maria ;
Rodrigues Silva, Lilian de Oliveira ;
Alves, Everton Giovanni ;
de Castro e Caldo Lima, Glaura Regina ;
Pereira, Alex Leite .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 24 :53-57
[8]   Molecular Epidemiology and Virulence Profiles of Colistin-Resistant Kiebsiella pneumoniae Blood Isolates From the Hospital Agency "Ospedale dei Colli," Naples, Italy [J].
Esposito, Eliana P. ;
Cervoni, Matteo ;
Bernardo, Mariano ;
Crivaro, Valeria ;
Cuccurullo, Susanna ;
Imperi, Francesco ;
Zarrilli, Raffaele .
FRONTIERS IN MICROBIOLOGY, 2018, 9
[9]   Prevalence of insertion sequence elements in plasmids relating to mgrB gene disruption causing colistin resistance in Klebsiella pneumoniae [J].
Fordham, Stephen Mark Edward ;
Mantzouratou, Anna ;
Sheridan, Elizabeth .
MICROBIOLOGYOPEN, 2022, 11 (01)
[10]   Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on [J].
Giordano, Cesira ;
Barnini, Simona ;
Tsioutis, Constantinos ;
Chlebowicz, Monika A. ;
Scoulica, Effie V. ;
Gikas, Achilleas ;
Rossen, John W. ;
Friedrich, Alexander W. ;
Bathoorn, Erik .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (02) :260-265